October 20, 2011
Takeda Pharmaceutical has adopted the “Enbrel MR” system from October in which its medical representatives (MR), who have frequent opportunities to provide information on the rheumatoid arthritis (RA) treatment Enbrel (etanercept) to orthopedics departments of university hospitals, will take charge...read more